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Abstract
Inflammation of the cutaneous orofacial tissue can lead to a prolonged alteration of neuronal and nonneuronal
cellular functions in trigeminal nociceptive pathways. In this study, we investigated the effects of experimentally
induced skin inflammation by dithranol (anthralin) on macrophage activation in the rat trigeminal ganglion. Tissue
localization and protein expression levels of ionized calcium-binding adaptor molecule 1 (Iba1), a macrophage/
microglia-specific marker, and proliferation/mitotic marker antigen identified by the monoclonal antibody Ki67
(Ki67), were quantitatively analyzed using immunohistochemistry and western blots in control, dithranol-treated,
dithranol- and corticosteroid-treated, and corticosteroid-treated trigeminal ganglia. Chronic orofacial dithranol treat-
ment elicited a strong pro-inflammatory effect in the ipsilateral trigeminal ganglion. Indeed, daily dithranol treatment
of the orofacial skin for 3–5 days increased the number of macrophages and Iba1 protein expression in the maxillary
subregion of the ipsilateral ganglion. In the affected ganglia, none of the Iba1-positive cells expressed Ki67. This
absence of mitotically active cells suggested that the accumulation of macrophages in the ganglion was not the result
of resident microglia proliferation but rather the extravasation of hematogenous monocytes from the periphery.
Subsequently, when a 5-day-long anti-inflammatory corticosteroid therapy was employed on the previously
dithranol-treated orofacial skin, Iba1 immunoreactivity was substantially reduced in the ipsilateral ganglion.
Collectively, our findings indicate that both peripheral inflammation and subsequent anti-inflammatory therapy affect
macrophage activity and thus interfere with the functioning of the affected sensory ganglion neurons.
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Introduction
Microglial cells belong to the monocyte/macrophage lineage
(Kreutzberg 1996; Prinz et al. 2011) and constitute an ontoge-
netically distinct population in the mononuclear phagocyte
system (Ginhoux et al. 2010). In nervous tissues, microglia
are ubiquitous as a continuum of multiple phenotypes, includ-
ing ameboid and extremely ramified morphologies. Under
physiological conditions, microglia display a ramified mor-
phology with subdued macrophage-like functional properties.
However, in response to neural injuries, infections, or inflam-
mation, microglia become activated, displaying a number of
characteristic morphological, molecular, immunological, and
functional changes (Kreutzberg 1996; Kettenmann et al. 2011;
Salter and Beggs 2014). This transformation parallels
microglial proliferation, and homing and adhesion to damaged
cells (Streit et al. 1999). In addition, this process is known to
be coupled to vigorous phagocytosis and phenotypic conver-
sion (Szabo and Gulya 2013). Indeed, the ameboid appear-
ance and the phagocytic nature of microglia coincide with
their antigen presentation capability and cytotoxic and
inflammation-mediating signalization (Town et al. 2005). In
tissues, microglia respond to both pro- and anti-inflammatory
signals and concomitantly produce pro- and anti-
inflammatory factors (Kata et al. 2016, 2017).
Dithranol (anthralin; 1,8-dihydroxy-9(10H)-anthracenone)
is widely used as an effective topical treatment for patients
with psoriasis (Hendriks et al. 2012). The precise molecular
basis for dithranol’s actions is believed to be related to the
production of free radicals and the keratinization of the epi-
dermis, along with its strong irritative and pro-inflammatory
properties (Sehgal et al. 2014). However, orofacial tissue in-
flammation can result in prolonged neuronal activation in
trigeminal nociceptive pathways. We previously reported that
chronic orofacial dithranol treatment results in a complete loss
of the pan-neuronal marker protein ubiquitin carboxyl-
terminal hydrolase L1 (UCH-L1, also known as PGP 9.5)
immunopositivity after 5 days (Orojan et al. 2006). In subse-
quent experiments, we demonstrated that dithranol treatment
transsynaptically downregulates the gene expression of the
intracellular calcium-binding protein calmodulin (CaM) in
rat principal sensory and motor trigeminal nuclei, in which
altered amounts of CaM mRNA were observed in response
to the treatment (Orojan et al. 2008). Aside from changes in
neurochemical markers, experimental manipulations of the
infraorbital branch of the trigeminal nerve (Xu et al. 2008)
and inflammation of the temporomandibular joint (Villa
et al. 2010) have been shown to cause a persistent increase
in the number of glial fibrillary acidic protein-positive satellite
cells in the trigeminal ganglion.
In this study, we investigated whether the induction of
chronic orofacial inflammation by dithranol or a subsequent
corticosteroid treatment resulted in an altered macrophage ac-
tivity in the trigeminal ganglion. Our findings draw attention
to the possibility that chronic peripheral inflammation, or anti-
inflammatory treatment, could affect neuronal functioning in
the trigeminal ganglion via macrophage activation.
Materials and methods
Animal handling and treatments
Experimental procedures were carried out in strict compliance
with the European Communities Council Directive (86/609/
EEC) and followed the Hungarian legislation requirements
(XXVIII/1998 and 243/1998) and university guidelines re-
garding the care and use of laboratory animals. All experimen-
tal protocols were approved by the Institutional Animal
Welfare Committee of the University of Szeged (I-74-II/
2009/MÁB). Adult (200–220 g) male Sprague Dawley rats
were maintained under standard housing conditions and kept
on a normal diet with tap water ad libitum and a 12-h light
cycle. The infraorbital region of the orofacial skin (about
1 cm2 around the whisker pad) on the right side of the animal
was treated daily with a Vaseline-based paste (petrolatum or
vaselinum album; Sigma, St. Louis, MO, USA) containing
10% dithranol (Sigma) for 3 or 5 days (Orojan et al. 2006,
2008). Approximately 90 and 150 mg of dithranol-containing
paste were applied for 3 and 5 days, respectively, to the surface
of the treated skin. The contralateral side of the animals re-
ceived only Vaseline paste and served as controls. After the
fifth day of dithranol treatment, one group of animals was
ipsilaterally treated daily for 5 days with a 0.1% corticosteroid
lotion (Elocon®; mometasone furoate, 9α,21-dichloro-
11β,17α-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione
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17α-(2-furoate); Schering, Kenilworth, NJ, USA).
Approximately 400 mg of mometasone furoate lotion was
applied at each time to the surface of the treated skin
(Orojan et al. 2006, 2008). Dithranol-treated animals began
to rub their perioral area, predominantly with their ipsilateral
paw (data not shown), within 1 h and continued to do so
throughout the entire treatment regimen. Reddened perioral
swelling was evident on the treated infraorbital region after
about 3 h. Rats receiving the vehicle did not exhibit paw-
related behavioral reactions or perioral inflammation. Rats
were decapitated on the day following the last treatment.
Histology
Following the different dithranol and/or corticosteroid treat-
ments, animals were transcardially perfused with 4% formal-
dehyde in 0.05 M phosphate-buffered saline (PBS). The tri-
geminal ganglia were quickly removed from the animals and
used for cryostat sectioning or embedded in paraffin for he-
matoxylin and eosin (H&E) staining and immunohistochem-
istry. Tissues were serially sectioned using a cryostat (20 μm)
on gelatin-coated glass slides and kept at − 20 °C until further
processing for histology and immunohistochemistry (up to 2
or 3 days). Paraffin-embedded sections were cut (6 μm) on a
microtome (Leica RM2235; Leica Mikrosysteme Vertrieb
GmbH, Wetzlar, Germany) and mounted on slides coated with
(3-aminopropyl)triethoxysilane (Menzel, Darmstadt,
Germany) and used for histology and immunohistochemistry.
Quantitative analyses of ionized calcium-binding adaptor
molecule 1 (Iba1)–positive macrophages and eosin-stained
neurons were performed in the maxillary subregion of the
contra- and ipsilateral ganglia (Fig. 1(a)), which is where
the cell bodies of most of the afferent fibers that innervate
the orofacial skin, upper lip, mystacial vibrissae, lateral nose,
and upper teeth are located (Waite and Tracey 1995).
Antibodies
For localization and quantitative analyses of macrophage phe-
notypes in the trigeminal ganglia, an antibody against the in-
tracellular actin- and Ca2+-binding protein, Iba1 (Szabo and
Gulya 2013), was used for immunohistochemistry and west-
ern blotting. An anti-proliferationmarker antigen identified by
the monoclonal antibody Ki67 (anti-Ki67) was used to detect
proliferating cells. Ki67 is a nuclear protein expressed in all
active phases of the cell cycle, from the late G1 phase through
the end of the M phase, but is absent in nonproliferating and
early G1 phase cells (Szabo et al. 2016; Cuylen et al. 2016).
The neuronal marker, the anti-NeuN antigen, was used to
identify ganglion cells (Beliczai et al. 2008). The anti-
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) anti-
body was used as an internal control in western blot experi-
ments (Wu et al. 2012). Appropriate dilutions of primary and
secondary antibodies, along with incubation times and
blocking conditions, were carefully determined for both im-
munohistochemistry and western blot analyses. In order to
detect the specificity of the secondary antibodies, omission
control experiments (i.e., staining without the primary anti-
body) were performed. In these experiments, no immunohis-
tochemical signals were observed.
Immunohistochemistry
Immunohistochemistry was performed as previously de-
scribed (Szabo and Gulya 2013). For light microscopic immu-
nohistochemistry, the endogenous peroxidase activity of the
Fig. 1 Cytoarchitecture of the rat trigeminal ganglion. (a) Localization of
the three neuron-containing subdivisions of the trigeminal ganglion in an
H&E-stained, paraffin-embedded tissue section of a control animal. (1)
Ophthalmic neurons, (2) maxillary neurons, and (3) mandibular neurons
(nomenclature adapted from Xu et al. (2008) and Waite and Tracey
(1995)). A quantitative microscopic analysis was performed on the
maxillary subregion of the trigeminal ganglion. Scale bar, 1 mm. (b)
Localization of Iba1-immunopositive macrophages around the
ganglionic cells in a 20 μm thick cryostat section from the maxillary
subdivision of the ganglion from a control rat. The majority of the mac-
rophages surround the ganglionic cells, whereas others are located within
the nerve fibers. Scale bar, 75 μm
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cryostat sections was blocked with 1% H2O2 in 0.05 M PBS
for 10 min at 37 °C. After washing in 0.05 M PBS three times
for 5 min, the samples were blocked and permeabilized in a
0.05 M PBS solution containing 0.1% Triton X-100, 5% nor-
mal goat serum (NGS), and 10% bovine serum albumin for
30 min at 37 °C. Sections were then incubated with a poly-
clonal rabbit antibody against Iba1 (final dilution 1:300;
Wako, Osaka, Japan) in the above solution at 4 °C overnight.
Sections were then washed several times in 0.05 M PBS,
followed by incubation with a biotinylated anti-rabbit immu-
noglobulin G (IgG) secondary antibody (final dilution 1:200;
Amersham Biosciences, Little Chalfont, Buckinghamshire,
UK) for 6 h at room temperature (RT). After several washes
in 0.05M PBS at RT, sections were incubated with a biotinyl-
ated streptavidin peroxidase tertiary antibody (final dilution
1:200; Amersham) at 4 °C overnight. Immunoreactivity was
visualized with the SigmaFast DAB tablet system (Sigma)
according to the manufacturer’s instructions. The sections
were then dipped in distilled water, stained with 0.5% eosin
solution for 30 s, dehydrated with ethanol, covered with a
DPX mounting medium (Fluka, Buchs, Switzerland), and
coverslipped. Representative microphotographs from the tri-
geminal ganglia were taken with a digital microscope camera
(QImaging MicroPublisher 3.3 RTV; QImaging Inc., Surrey,
BC, Canada) attached to a Leica DMLB microscope (Leica).
Image processing was performed using the QCapture Pro 6.2
software for Windows (QImaging Inc.). The areas of ganglion
cells and macrophages were counted from five fields of view
in four sections for each animal (n = 4–6 rats in each treatment
group) using a × 40 objective. The investigator was blind to
the treatments of the samples.
For fluorescent immunohistochemistry, paraffin-embedded
tissue sections were deparaffinized, rehydrated, and placed in
a jar filled with 0.01 M citrate buffer (pH 6.0) containing
0.05% Tween 20 and heated at 95 °C for 20 min. The sections
were washed 3 × 10 min in 0.05 M PBS containing 0.05%
Tween 20 and blocked in 0.05 M PBS solution containing
0.05% Tween 20 and 5% NGS for 1 h at RT. The sections
were then incubated with rabbit polyclonal anti-Iba1 (final
dilution 1:300; Wako) antibody, mouse monoclonal anti-
NeuN antibody (1:100 final dilution; Chemicon, Temecula,
CA, USA), or mouse monoclonal anti-Ki67 IgG (final dilution
1:500; Cell Signaling Technology, Danvers, MA, USA) in a
0.05 M PBS solution containing 0.05% Tween 20 and 5%
NGS overnight at 4 °C. After washing (4 × 10 min in
0.05M PBS containing 0.05% Tween 20), primary antibodies
were labeled fluorescently with either Alexa 568–conjugated
anti-rabbit IgG or Alexa 488–conjugated anti-mouse IgG sec-
ondary antibody (final dilution for both 1:1000; Invitrogen,
Carlsbad, CA, USA) in a blocking solution for 3 h at RT.
After 4 × 10 min washes in 0.05 M PBS containing 0.05%
Tween 20, cell nuclei were stained in 0.05 M PBS containing
1 mg/mL polyvinylpyrrolidine and 0.5 μL/mLHoechst 33258
dye (Invitrogen). Sections were finally washed 2 × 5min in
0.05 M PBS containing 1 mg/mL polyvinylpyrrolidine, cov-
ered with VECTASHIELD (Vector Laboratories,
Peterborough, UK), and coverslipped. The sections were then
viewed on a Nikon Microphot-FXA epifluorescence micro-
scope (Nikon Corp., Tokyo, Japan) and photographed with a
Spot RT Color CCD camera (SPOT RT/KE; Diagnostic
Instruments, Inc., Sterling Heights, MI, USA).
Western blot analysis
The trigeminal ganglia were removed and individually homoge-
nized in 50 mM Tris-HCl (pH 7.5 at 4 °C) containing 150 mM
NaCl, 0.1% Nonidet P-40, 0.1% cholic acid, 2 μg/mL leupeptin,
1 μg/mL pepstatin, 2 mM phenylmethylsulfonyl fluoride, and
2 mM EDTA and centrifuged at 14,000×g for 10 min at 4 °C.
The pellets were discarded and the protein concentrations from
the supernatants were determined (Lowry et al. 1951). Western
blot analysis was performed as previously described (Szabo and
Gulya 2013). Equal amounts of proteins in the linear range of
detection on a polyacrylamide gel (Aldridge et al. 2008) were
loaded. Briefly, protein samples (25 μg) denatured at 100 °C for
5 min were loaded to wells and separated on 12% sodium dode-
cyl sulfate (SDS)–polyacrylamide gels and transferred onto
Hybond ECL nitrocellulose membranes (Amersham
Biosciences), blocked in 5% nonfat dry milk in 0.1 M Tris-
buffered saline (TBS) containing 0.1% Tween 20 for 1 h, and
then incubated with either a rabbit anti-Iba1 polyclonal antibody
(dilution 1:1000; Wako) or a mouse anti-GAPDH monoclonal
antibody (clone GAPDH-71.1; 1:20,000 final dilution; Sigma).
Nonspecifically bound or excess antibody was removed with
5 × 5 min rinses in 0.1 M TBS containing 0.1% Tween 20.
Membranes were then incubated for 1 h with either peroxidase-
conjugated goat anti-rabbit or peroxidase-conjugated rabbit anti-
mouse antibody (dilution 1:2000; Jackson ImmunoResearch
Europe Ltd., Cambridgeshire, UK) and washed three times.
The enhanced chemiluminescence method (ECL plus western
blotting detection reagents; Amersham) was used to reveal im-
munoreactive bands according to the manufacturer’s instructions.
Image and statistical analyses
Digital microscopic images were acquired with a Nikon
Microphot-FXA epifluorescence microscope (Nikon Corp.)
using a Spot RT Color CCD camera and Spot RT software
(Spot RT/KE; Diagnostic Instruments, Inc.). Cross-sectional
areas of Iba1 immunopositive macrophages and eosin-stained
neurons were measured in the pictures taken from the maxil-
lary infraorbital region of the trigeminal ganglia (Fig. 1 (a) and
(b)). Digital image production was performed with the Adobe
Photoshop CS5.1 software (Adobe Systems, Inc., San Jose,
CA, USA). Color correction (brightness, contrast) and
cropping of the fluorescent images were occasionally
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performed when individual photomicrographs were assem-
bled as figure panels for publication.
Paraffin-embedded tissue sections (6 μm) of the trigeminal
ganglia were deparaffinized, rehydrated, and processed for
Iba1 immunohistochemistry (Fig. 2(a), (d)). The sections were
counterstained with eosin, dehydrated, and covered with DPX
mountingmedium. Iba1 immunoreactive cell images or eosin-
stained neurons were converted into binary replicas by using
threshold procedures implemented by Photoshop and ImageJ
(version 1.47; developed at the US National Institutes of
Health by W. Rasband, available at https://imagej.net/
Downloads; Schneider et al. 2012) as we published earlier
(Szabo and Gulya 2013; Kata et al. 2016; Szabó et al.,
2016). Briefly, digital images in tagged image file formats
(.tif) were opened in Photoshop; then, threshold was set in
the Adjustment menu until silhouettes overlapped Iba1-
labeled cells and processes (Fig. 2(b), (e)) or the eosin-
counterstained ganglion cells (Fig. 2(c), (f)). Areas of macro-
phages and neurons were measured with the use of the com-
puter program ImageJ. Saved images were opened in ImageJ,
where image type was set to 8 bit and the Process menu was
selected to make binary silhouettes. The Set Scale menu was
then selected, and the following parameters were set: distance
in pixel, 420; known distance, 75; pixel aspect ratio, 1.0; unit
of length, μm. Analyze particles menu was selected, where
size and circularity were set to 0-infinity and 0-1, respectively.
Displayed results were copied to Excel (Microsoft Corp.,
Redmond, WA, USA) and analyzed. Twenty fields in four
sections for every treatment group were statistically analyzed
with one-way analysis of variance (ANOVA) using SigmaPlot
v.12.3 (Systat Software, Inc., San Jose, CA, USA).
Grayscale digital images of the western blots were acquired
by scanning the autoradiographic films with a desktop scanner
(Epson Perfection V750 Pro; Seiko Epson Corp., Nagano,
Japan). Images were scanned and processed at identical set-
tings to allow comparisons of the western blot results from
different samples. The immunoreactive densities of lanes
equally loaded with protein were quantified, and all samples
were normalized to the internal GAPDH load controls as we
previously reported (Kata et al. 2016, 2017). For western blot-
ting, one-way ANOVA (SigmaPlot) or Student’s t test was
used for statistical comparisons. Values are presented as the
mean ± standard error of the mean (SEM) from at least four
immunoblots, each representing an independent experiment.
A p value of < 0.05 was considered significant; * denotes
p < 0.05.
Results
The three subregions (ophthalmic, maxillary, mandibular) of
the trigeminal ganglion are shown in Fig. 1(a). In control rats,
only few Iba1-immunopositive macrophages surround neu-
rons in the maxillary subregion (Figs. 1(b) and 2(a)). Daily
Fig. 2 Quantitation of macrophage area/neuron area in the maxillary
subdivision of the trigeminal ganglion. Iba1 immunohistochemistry and
quantitative data from the maxillary subregions of ganglia obtained from
control (a, b, c) and dithranol-treated (d, e, f) animals are shown. Paraffin-
embedded tissue sections were processed for Iba1 immunohistochemistry
and counterstained with eosin. Cross-sectional areas of macrophages and
neurons were identified and measured in digital images as described in
“Materials and methods.” (a), (d) Iba1 immunohistochemistry; (b), (e)
binary silhouettes of Iba1-labeled cells (c), (f) binary silhouettes of
eosin-counterstained neurons. Scale bar in (a), 100 μm
Cell Tissue Res
dithranol treatment to the infraorbital region of the orofacial
area for 3 and 5 days caused severe skin inflammation (for a
histological evaluation, see Orojan et al. 2006). Light micro-
scopic immunohistochemistry revealed that 5-day-long
dithranol treatment increased the amounts of Iba1-
immunoreactive components (Fig. 2(d), (e)) in the maxillary
subdivision of the ganglion over the control samples (Fig.
2(a), (b)). Quantitative immunohistochemical analysis re-
vealed that the macrophage area/neuron area ratio in the max-
illary subregion was significantly increased (*p < 0.05) after
5 days of dithranol treatment as compared with controls
(Fig. 3). Steroid treatment alone did not affect the macrophage
area/neuron area ratios. When the dithranol treatment was
followed by a 5-day-long corticosteroid treatment to the same
orofacial skin region, the macrophage area/neuron area ratio
was lowered, albeit non-significantly, in the maxillary subre-
gion of the ganglia.
Western blot analyses confirmed that the effect of dithranol
was dose-dependent, as only the 5-day-long dithranol treat-
ment increased Iba1 immunoreactivity significantly in the af-
fected ganglion (Fig. 4(a)). In addition, when corticosteroid
was applied to the dithranol-treated orofacial area for 5 days, a
significant decrease in Iba1 immunoreactivity was observed in
the ipsilateral trigeminal ganglion by western blot analysis
(Fig. 4(b)). Corticosteroid treatment alone for 5 days was in-
effective as it did not change the immunoreactive signal of the
blot significantly as compared with the controls.
Double immunofluorescence histochemistry (Fig. 5) cor-
roborated the results of the western blotting, as the Iba1-
positive macrophage profiles (sections of somata and process-
es) increased after dithranol treatment (Fig. 5(b)). In order to
examine whether the increased number of Iba1-expressing
cells in the ipsilateral trigeminal ganglia after dithranol treat-
ment was the result of resident macrophage proliferation, dou-
ble immunofluorescent histochemistry was performed using
both Iba1 and Ki67 antibodies. Condensed chromatin in M
phase and/or Ki67 immunoreactivity from late G1 to late M
phase (both are markers of cellular proliferation/mitotic activ-
ity) in Iba1-expressing macrophages was not observed in the
ganglion (Fig. 6 (b) and (f)). Thus, Iba1-positive cells in the
ganglion likely represented recently migrated macrophages
into the maxillary subregion of the ganglion rather than pro-
liferating resident macrophages.
Discussion
The innervation territories of the three main divisions of the
trigeminal nerve in rodents are well established (Waite and
Tracey 1995). In the rat, the maxillary division of the trigem-
inal nerve innervates infraorbital skin around the whisker pad,
providing both deep and superficial nerves to the vibrissal
follicles. Experimentally induced lesions (Takahashi et al.
2011; Xu et al. 2008) and pharmacological interventions
(Cady et al. 2010) targeting the trigeminal nerve result in
neuroanatomical and chemical alterations of both the neuronal
and the glial components of the trigeminal ganglion. For ex-
ample, herpes simplex virus infection (Mori et al. 2003) or
lipopolysaccharide-induced systemic inflammation
(Franceschini et al. 2013) increases the number of Iba1-
immunoreactive macrophages in the ganglion. Iba1 is a
calcium-binding protein (Ahmed et al. 2007) that is expressed
not only in the microglia of the central nervous system (CNS)
but also in the macrophages of the peripheral nervous system
(PNS), including the trigeminal ganglion (Glenn et al. 1993).
In a previous study, we demonstrated that chronic dithranol
treatment causes severe, but corticosteroid-reversible, inflam-
mation in the infraorbital region of the orofacial skin, which
results in a complete loss of the pan-neuronal marker UCHL-1
(also known as PGP9.5) in the nerve fibers of the affected skin
area (Orojan et al. 2006). The action of dithranol is believed to
be mediated by the generation of reactive oxygen species and
anthrone radicals that ignite a series of pro-inflammatory path-
ways that can eventually destroy nerve endings (Orojan et al.
2006). Damage to peripheral nerves results in marked
Fig. 3 The macrophage area/neuron area ratio increases after dithranol
treatment in the maxillary subdivision of the trigeminal ganglion. The
orofacial skin was treated with dithranol for 5 days, dithranol for 5 days
followed by corticosteroid for 5 days, and corticosteroid for 5 days. A
quantitative analysis of the macrophage/neuron ratio in the maxillary
subregion of the trigeminal ganglion was carried out by computing the
cross-sectional areas of Iba1-immunopositive macrophages and eosin-
counterstained ganglion cells on tissue sections from controls and
treated animals. A 5-day-long dithranol treatment significantly
increased the macrophage area/neuron area ratio (*p < 0.05; one-way
ANOVA with Dunn’s post hoc test) in the maxillary subregion. This
ratio decreased, albeit non-significantly, in dithranol + steroid-treated
ganglia. Steroid treatment alone was without effect on this ratio. Area
measurements were made in 4 non-overlapping but adjacent fields of
view from four nonconsecutive sections for each animal (n = 4–6 rats in
each experimental group). Data are presented as the mean ± SEM of the
ratio of Iba1-positive cell areas to eosin-stained ganglionic cell areas
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microgliosis in the somatotopically relating central projection
territories of the affected nerve (Gilmore and Skinner 1979;
Beggs and Salter 2007). Similarly, inflammatory processes in
the trigeminal region, for example, in the temporomandibular
joint, elicit activation ofmicroglia in both the spinal trigeminal
nucleus and the trigeminal ganglion (Villa et al. 2010). In the
present study, we demonstrated a marked increase in the total
cross-sectional area of Iba1-immunoreactive macrophages in
the maxillary subregion of the trigeminal ganglion following a
dithranol-induced cutaneous inflammatory reaction in the
orofacial region of the rat. Activated microglia produce pro-
inflammatory cytokines (Streit et al. 1998; Takahashi et al.
2011) and increase the synthesis of Iba1 (Szabo and Gulya
2013). Consistent with previous in vivo (Endo et al. 2014;
Kiefer and Kreutzberg 1991) and in vitro (Hinkerohe et al.
2010) results, corticosteroid treatment administered alone to
the ipsilateral orofacial skin did not affect macrophage prolif-
eration or Iba1 production in the trigeminal ganglion but was
able to reduce the effects of dithranol-induced inflammation.
It can be debated whether this response is due to the local
proliferation of Iba1-positive cells or an increased influx of
macrophages from the blood. Indeed, during inflammation,
one of the most important processes is leukocyte extravasation
(Lange et al. 1998). In addition, there may be differences in
microglia/macrophage activation and proliferation between
the CNS and PNS as a consequence of harmful stimuli
(Leskovar et al. 2000; Greenhalgh and David 2014).
However, it is difficult to identify hematogenousmacrophages
and distinguish them from resident tissue macrophages, as
they both share the same marker proteins, such as Iba1,
CD68, and CX3C chemokine receptor 1 (CX3CR1). These
cell types can be crudely distinguished on the basis of differ-
ing levels of cluster of differentiation 45 (CD45) or C-C che-
mokine receptor type 2 (CCR2) proteins (David and Kroner
2011) and their differential susceptibility to radiation
(Matsumoto and Fujiwara 1987). Nonetheless, their discrimi-
nation becomes even more difficult as infiltrating macro-
phages quickly become indistinguishable from resident
macrophages.
Experiments using bone marrow chimeras with lethally
irradiated recipients have been conducted in order to over-
come this issue. It has been concluded in many of these studies
that bone marrow–derived monocytes can cross the blood–
brain barrier (BBB) and differentiate into parenchymal mi-
croglia of the brain or spinal cord (Djukic et al. 2006;
Echeverry et al. 2011; Sawada et al. 2014; Zhang et al.
Fig. 4 Orofacial tissue inflammation and subsequent corticosteroid
treatment antagonistically regulate Iba1 protein levels in the trigeminal
ganglia. Whole ganglia were used in this experiment. Contra- (control)
and ipsilateral (treated) ganglia were separately homogenized, and 25 μg
of protein was subjected to SDS-polyacrylamide gel electrophoresis.
Protein bands were transferred to nitrocellulose membranes and assayed
for reactivity toward a polyclonal rabbit antibody directed against the Iba1
protein. (a) Iba1 immunoreactivity was altered dose-dependently in the
ipsilateral ganglia. After 5 days of dithranol treatment, a significant
increase in Iba1 immunopositivity was detected (*p < 0.05) in the
ipsilateral trigeminal ganglion as compared with controls (24,611 ±
3628 and 16,142 ± 1580 specific integrated optical density values,
respectively). This effect was dose-dependent, as only the larger dose of
dithranol was effective. (b) Corticosteroid antagonized the effect of
dithranol with regard to the Iba1 content of the trigeminal ganglion, as
demonstrated by integrated optical density values normalized to the
internal GAPDH load controls. A chronic, 5-day-long dithranol
treatment regimen significantly elevated this immunoreactivity, whereas
a subsequent 5-day-long corticosteroid treatment regimen significantly
depleted this immunoreactivity (*p < 0.05; one-way ANOVA with
Tukey’s post hoc test)
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Fig. 5 Orofacial tissue inflammation increases, while subsequent
corticosteroid treatment decreases, Iba1 immunoreactivity in the
maxillary subdivision of the trigeminal ganglion. After a 5-day-long
dithranol treatment regimen, rats were transcardially perfused and the
contra- and ipsilateral trigeminal ganglia were removed, embedded in
paraffin, and sectioned. In these composite images, Iba1- and NeuN-
expressing macrophages (red) and neurons (green), respectively, were
detected by double fluorescence immunohistochemistry. Cell nuclei
(blue) were stained with Hoechst 33258 dye. (a) Iba1 and NeuN
immunoreactivities in the maxillary subregion of the contralateral
(control) trigeminal ganglion after sham treatment. (b) Iba1
immunoreactivity increased after a chronic, 5-day-long dithranol
treatment regimen in the maxillary subregion of the ipsilateral
trigeminal ganglion. (c) Corticosteroid treatment alone did not have any
effect on Iba1 immunoreactivity as compared with the contralateral
(control) trigeminal ganglion. (d) When the dithranol treatment was
followed by a 5-day-long corticosteroid treatment on the same orofacial
skin area, a decrease in Iba1 immunoreactivity was detected. Scale bar,
100 μm
Fig. 6 The number of Iba1-immunopositive cells increases in the
maxillary subdivision of the trigeminal ganglion without an increase in
the number of mitotic cells. The vast majority of Iba1-expressing cells in
the maxillary subregion of the trigeminal ganglion were devoid of Ki67
immunoreactivity after dithranol treatment, indicating the absence of
mitotic cells. The number of Iba1-expressing cells (red) increased after
dithranol treatment in the ipsilateral ganglion (e) as compared with the
contralateral side (a). The absence of Ki67-labeled mitotic cells (green)
(b, f) suggested that the many Iba1-positive cells detected after dithranol
treatment were hematogenous macrophages that migrated recently to the
ganglion (f). Cell nuclei (blue) were stained with Hoechst 33258 dye (c,
g). Merged pictures are shown (d, h). Scale bar, 100 μm
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2007). For example, Menasria et al. (2015) provided evidence
that blood monocyte–derived macrophages infiltrate the brain
in experimental herpes simplex virus 1 encephalitis and the
infiltrating cells from the monocytic lineage differentiate into
activated, Iba1-expressing resident tissue macrophages.
However, Schilling et al. (2003) demonstrated using bone
marrow chimeric mice that resident microglial activation
preceded and predominated over macrophage infiltration in
transient focal cerebral ischemia. Furthermore, Gu et al.
(2016) showed that the proliferation of resident microglial
cells, rather than monocyte infiltration from the blood, was
the major contributor to microgliosis in the dorsal horn of
the spinal cord after peripheral nerve injury. Similar results
were reported by Feng et al. (2019) in an epileptic brain,
where resident microglia, but not infiltrated monocytes, were
responsible for the hippocampal proliferation of microglial
cells after a kainic acid–induced seizure. It has also been re-
ported in recent studies that circulating cells do not infiltrate
into the brain parenchyma without irradiation and transplan-
tation or in large quantities (Ajami et al. 2007; Li et al. 2013),
which raises the consideration that monocytes may not cross
the intact BBB under certain pathological conditions, thus
complicating the issue further.
Other experimental approaches have been used to investi-
gate monocyte invasion of peripheral nervous tissue. Using
bone marrow chimeric rats, Mueller et al. (2003) identified
and quantified hematogenous and resident endoneurial mac-
rophages after sciatic nerve crush injury. The authors found
that both resident macrophages and blood-borne monocytes
contribute significantly to the total endoneurial macrophage
pool during Wallerian degeneration. When the longevity of
such macrophages in the PNS of these chimeric animals was
further investigated (Müller et al. 2010), a maximal turnover
of 75% of hematogenous macrophages was observed, with
only a small resident macrophage population. In our studies,
we used an alternative method to establish whether resident
macrophages respond with increased mitotic activity to nox-
ious stimuli or increased infiltration of monocytes entering the
ganglion. Our data revealed that the area of Iba1-
immunopositive macrophages significantly increased after
dithranol treatment, but this was not in conjunction with an
increased number of Ki67-labeled cells. Thus, the lack of mi-
totic activity eliminated the possibility that resident macro-
phages were the source of the increased number of Iba1-
positive cells. Therefore, our findings indicated that the mi-
gration of peripheral macrophages into the trigeminal gangli-
on was responsible for the increased number of Iba1-positive
cells in the ganglion. These data raised the possibility that the
microglia/macrophage pools in central and peripheral nervous
tissues are maintained differently and that monocyte invasion
to the peripheral endoganglionic or endoneurial space is easier
than to the parenchyma of the CNS during certain neuropath-
ological or inflammatory events.
Collectively, our novel findings provide further proof that
peripheral inflammation, as well as subsequent anti-
inflammatory therapy, interferes with the regulation of mac-
rophage activation and could affect neuronal activity both in
the periphery and in the CNS (Salter and Beggs 2014;
Spangenberg et al. 2016). Further work on the in vivo cellular
interactions and mechanisms involved in neuroinflammation
and microglia/macrophage proliferation may help to under-
stand the development of neuropathic pain hypersensitivity
and neuronal loss.
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